Glenmark launches antidiabetic drug in India

The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.

Related Keywords

India ,Alok Malik ,Glenmark Pharmaceuticals On ,Glenmark Pharmaceuticals ,Drug Controller General ,Pharmaceuticals President ,Business Head India Formulations ,Business ,Companies , ,